Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia von Place, Andrew E., Pikman, Yana, Stevenson, Kristen E., Harris, Marian H., Pauly, Melinda, Sulis, Maria‐Luisa, Hijiya, Nobuko, Gore, Lia, Cooper, Todd M., Loh, Mignon L., Roti, Giovanni, Neuberg, Donna S., Hunt, Sarah K., Orloff‐Parry, Sarah, Stegmaier, Kimberly, Sallan, Stephen E., Silverman, Lewis B.

Volltext